Showing results (421-430 of 1,835) with videos related to
Sort By:
Pageof 184
ESMO Open|June 8, 2026
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancerE Salehi, X Chu, E L Mayer, et al.ESMO Open|July 16, 2026
Monoallelic BRCA1/2 variants in pediatric, adolescent, and young adult patients with central nervous system tumorsS Cipri, E Agolini, G D Baldo, et al.ESMO Open|July 16, 2026
Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAFM Bartolini, S Algaze, H-J LenzESMO Open|July 24, 2026
Superselective intra-arterial chemoradiotherapy for maxillary sinus squamous-cell carcinoma: results from the T4bN0M0 cohort of JCOG1212H Tachibana, K Matsuura, R Onimaru, et al.ESMO Open|July 21, 2026
Eribulin versus taxane as first-line chemotherapy combined with dual HER2 blockade in patients with HER2-positive locally advanced or metastatic breast cancer: final survival outcomes of the JBCRG-M06/EMERALD studyS Saji, T Yamashita, J Tsurutani, et al.ESMO Open|July 29, 2026
Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targetsA Rametta, M Stellato, S Rota, et al.ESMO Open|July 24, 2026
Platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in metastatic urothelial carcinoma: a real-world studyM Sternschuss, K Whiting, A Arbuiso, et al.ESMO Open|August 4, 2026
Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancerE Nicolò, J L Sandoval, L Foffano, et al.ESMO Open|September 8, 2026
Pseudoprogression in neoadjuvant immunotherapy for resectable NSCLC: a PET-CT-based studyY Pan, J Chen, H Lin, et al.ESMO Open|September 8, 2026
Liquid biopsy: a new window on the BRCA genesL Incorvaia, V Gristina, F Pepe, et al.Pageof 184